Last reviewed · How we verify
NCT04095091
Real-time Tumor Localization and Guidance for Radiotherapy Using Ultrasound (US) and Magnetic Resonance (MR)
trial testing 4D Planar US Transducer in Tumor, Solid in 30 participants. Terminated before completion.
4 October 2019
Quick facts
| Lead sponsor | University of Wisconsin, Madison |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 14 September 2017 |
| Primary completion | 4 October 2019 |
| Estimated completion | 4 October 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- 4D Planar US Transducer
Conditions studied
- Tumor, Solid — all drugs for Tumor, Solid →
Sponsor
University of Wisconsin, Madison
Who can join
18 and older, any sex, with Tumor, Solid. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this protocol is to evaluate the feasibility of acquiring simultaneous 4D ultrasound and 4D MRI scans. The imaging performance of the US and MRI scans will be characterized. The secondary objective of this study is to determine if several salient features identified in the US scan can be used to predict target motion identified in the MR scan.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04095091
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tumor, Solid
Currently open trials in the same condition.
- NCT07348042 — Study of RGL-270 Single Drug and Combined With Adebelimab in Patients in Patients at High Risk of Recurrence After Radic · Phase 1 · recruiting
- NCT06987500 — A Study of PARG Inhibitor XNW29016 in Patients With Advanced Solid Tumors Who Failed Standard Treatment · Phase 1, PHASE2 · recruiting
- NCT06911333 — AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors · Phase 1, PHASE2 · recruiting
- NCT07433283 — Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor · Phase 1, PHASE2 · recruiting
- NCT04723810 — TumorGlow Intraoperative Molecular Imaging (IMI) · Phase 1, PHASE2 · recruiting
Other University of Wisconsin, Madison trials
Trials by the same sponsor.
- NCT07440004 — Testing a Digital Mindfulness Program to Support People Experiencing Suicidal Thoughts · Phase 1 · recruiting
- NCT07278466 — The COMParing App Support Strategies Study · NA · recruiting
- NCT07475104 — Redesigning Surgical Care for Patients in Wisconsin · NA · enrolling by invitation
- NCT07470723 — The ORIGIN-FH Study · NA · recruiting
- NCT06975657 — Well-being Skills for Reentry · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04095091 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Wisconsin, Madison
- Last refreshed: 31 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04095091.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing